Herpes simplex virus (HSV)-specific human T-cell clones recognize HSV glycoprotein D expressed by a recombinant vaccinia virus.
about
Asymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein BImmunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects.Anchor sequence-dependent endogenous processing of human immunodeficiency virus 1 envelope glycoprotein gp160 for CD4+ T cell recognition.Fine mapping of antigenic site II of herpes simplex virus glycoprotein DExpression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.Antigenic analysis of a major neutralization site of herpes simplex virus glycoprotein D, using deletion mutants and monoclonal antibody-resistant mutantsHerpes simplex virus (HSV)-specific proliferative and cytotoxic T-cell responses in humans immunized with an HSV type 2 glycoprotein subunit vaccine.Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D.Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes.Evaluation of pseudorabies virus glycoprotein gp50 as a vaccine for Aujeszky's disease in mice and swine: expression by vaccinia virus and Chinese hamster ovary cellsHigh-level expression of glycoprotein D by a dominant-negative HSV-1 virus augments its efficacy as a vaccine against HSV-1 infection.Genetically engineered poxviruses for recombinant gene expression, vaccination, and safetyPolymorphism within the herpes simplex virus (HSV) ribonucleotide reductase large subunit (ICP6) confers type specificity for recognition by HSV type 1-specific cytotoxic T lymphocytes.Herpes simplex virus-infected human fibroblasts are resistant to and inhibit cytotoxic T-lymphocyte activity.Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity.A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection.Varicella-zoster virus-specific cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood.Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses.
P2860
Q30847945-18334E75-A137-4B80-86E1-C03FCCFC0F12Q35854117-DF9F8FEF-B25F-4674-BBD8-0D4ADABF5A97Q36350632-79E2CCF8-7624-49A3-9F6C-56E8ED55B397Q36827612-1B7D0782-32CB-4037-8626-DCFBF6A7CC58Q36830970-FFEE4EC2-3DBA-4FE4-99C4-743F838067C9Q36872389-5959EDDD-F9D5-4DEE-8358-A5DB6B2DF495Q36873354-AAFE8FA4-7851-4AEF-850D-FCE2D8CBB49AQ36898071-72E67583-2DC3-48F5-B791-93B4441418ABQ36916007-AD9F141C-1903-4B5D-862F-3B85021E4D85Q36920514-0487C76D-A8A7-4830-BB9C-A386F5470E92Q37160338-5876FFAA-2692-432E-8B65-2E12F39CA133Q37249251-FE65296B-2BA4-4D59-8F10-2853A78D0007Q39868823-CCBE73AF-3458-4313-ABFE-C42D7CE29641Q40060604-8A638966-EE04-4E43-8B7F-C956FF5018B6Q40108953-170D374E-EE53-4180-813C-3860FAEA3351Q40127728-B65DC648-082B-4295-92E4-7CBD1C0F6089Q40141112-64446D89-60A7-4D58-B6D6-9A0C238DA46AQ42120952-D33C9DC7-7638-474B-AFC9-B671D01C7F25
P2860
Herpes simplex virus (HSV)-specific human T-cell clones recognize HSV glycoprotein D expressed by a recombinant vaccinia virus.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Herpes simplex virus (HSV)-spe ...... a recombinant vaccinia virus.
@en
type
label
Herpes simplex virus (HSV)-spe ...... a recombinant vaccinia virus.
@en
prefLabel
Herpes simplex virus (HSV)-spe ...... a recombinant vaccinia virus.
@en
P2093
P2860
P1433
P1476
Herpes simplex virus (HSV)-spe ...... a recombinant vaccinia virus.
@en
P2093
P2860
P304
P407
P577
1986-08-01T00:00:00Z